UAE Neurology Devices Market Size (2024 - 2029)

The UAE neurology devices market is anticipated to experience stable growth, driven by an increasing prevalence of neurological disorders and significant investments in the sector. The market's expansion is supported by the rising geriatric population and the growing use of innovative treatment options for conditions such as brain aneurysms. Despite the initial impact of the COVID-19 pandemic on neurology care and device usage, the market is recovering as normalcy returns. However, the high cost of equipment poses a challenge to market growth.

Market Size of UAE Neurology Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
UAE Neurology Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 4.80 %
Market Concentration Medium

Major Players

UAE Neurology Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

UAE Neurology Devices Market Analysis

The UAE neurology devices market is expected to register a CAGR of 4.8% during the forecast period.

  • The COVID-19 pandemic significantly impacted neurology care in UAE during the initial phase, which in turn impacted the usage of neurology devices as well. For instance, according to an article published by Hindawi in August 2021, a study was conducted in Abu Dhabi, UAE, which showed that the patients infected with COVID-19 often presented with neurological manifestations in the form of headache, dizziness, hyposmia, myalgia, peripheral neuropathy, acute cerebrovascular disease, and encephalopathy. The source also stated that neurological involvement could be due to virus-induced brain hypoxia, brain infection, or immune reaction. Thus, the COVID-19 pandemic significantly impacted the market initially; however, as the pandemic has currently subsided, neurology care is going back to normal in the UAE. Hence, the studied market is expected to have stable growth during the forecast period of the study.
  • The key factors propelling the growth of the studied market are the increasing burden of neurological disorders, huge investments by private players in neurology devices, and the rising geriatric population in the country.
  • The increasing incidence of neurological disorders like brain aneurysms, brain tumors, and epilepsy, among others, is the major factor driving the market growth. For instance, according to an article published by Multidisciplinary Digital Publishing Institute (MDPI) in June 2022, a study was conducted in UAE that stated that a brain aneurysm is a critical condition that mostly affects young adults and may cause life-threatening complications such as brain hemorrhage.
  • Furthermore, patients with untreated unruptured aneurysms have 50% excess long-term mortality compared with the general population, and one of the most innovative treatment options for brain aneurysms is the use of a flow-diverting stent (FDS). Thus, the high burden of diseases such as brain aneurysms and the increasing use of neurology devices such as FDS are expected to boost market growth.
  • Furthermore, according to an article published by PubMed Central in November 2022, brain and central nervous system cancer was among the most common forms of cancer in the UAE. Thus, the high prevalence of such neurological disorders is expected to enhance the usage of neurological devices. Moreover, as these neurological diseases mostly occur in the elderly population, the rising geriatric population in the country is also expected to enhance market growth.
  • Thus, the aforementioned factors, such as the rising prevalence of neurological disorders and the increasing research and development activities, are expected to boost the market growth during the forecast period of the study. However, the high cost of equipment is expected to impede the market growth.

UAE Neurology Devices Industry Segmentation

Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury.

The UAE neurology devices market is segmented by type of device (cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and other types of devices).

The report offers the value (in USD) for the above segments.

By Type of Device
Cerebrospinal Fluid Management Devices
Interventional Neurology Devices
Neurosurgery Devices
Neurostimulation Devices
Other Types of Devices
Need A Different Region Or Segment?
Customize Now

UAE Neurology Devices Market Size Summary

The UAE neurology devices market is poised for stable growth, driven by the increasing prevalence of neurological disorders and significant investments in the sector. The market experienced initial disruptions due to the COVID-19 pandemic, which affected neurology care and device usage. However, as the situation has normalized, the market is expected to expand steadily. Key factors contributing to this growth include the rising incidence of conditions such as brain aneurysms, tumors, and epilepsy, alongside a growing geriatric population. The demand for innovative treatment options, like flow-diverting stents for brain aneurysms, is also expected to enhance market dynamics. Despite the high cost of equipment posing a challenge, the market is supported by ongoing research and development activities.

The neurostimulation and neurosurgery device segments are anticipated to experience growth due to the increasing burden of conditions like urinary incontinence and the rising adult and geriatric population. Neurostimulation devices are gaining traction for their effectiveness in treating chronic pain and movement disorders, while neurosurgery devices are crucial for addressing various neurological diseases. The high prevalence of Parkinson's disease and dementia in the UAE further propels the demand for these devices. The market is moderately fragmented, with major players like Stryker Corporation, Medtronic PLC, and Abbott Laboratories actively involved in developing advanced technologies. Recent developments, such as the establishment of a biplane angio neuroradiology suite and clinical trials for innovative therapies, underscore the market's potential for growth.

Explore More

UAE Neurology Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Burden of Neurological Disorders

      2. 1.2.2 Huge Investments by Private Players in Neurology Devices

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Equipment

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value in USD)

    1. 2.1 By Type of Device

      1. 2.1.1 Cerebrospinal Fluid Management Devices

      2. 2.1.2 Interventional Neurology Devices

      3. 2.1.3 Neurosurgery Devices

      4. 2.1.4 Neurostimulation Devices

      5. 2.1.5 Other Types of Devices

UAE Neurology Devices Market Size FAQs

The UAE Neurology Devices Market is projected to register a CAGR of 4.80% during the forecast period (2024-2029)

Stryker Corporation, Medtronic PLC, Abbott Laboratories, Nihon Kohden Corporation and Johnson and Johnson are the major companies operating in the UAE Neurology Devices Market.

UAE Neurology Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)